TP53INP1 is downregulated during tumorigenesis in most cancers, including pancreatic cancer, gastric carcinoma, hepatocellular carcinoma, and melanoma, suggesting that it may play a role in tumor suppression and cell death [34–37]. Here, TP53INP1 is linked to pancreatic neoplasm.